top of page

Opioid Use Disorder

Asynchronous (On Demand)

August 10, 2023 – December 31, 2023

Opioid Use Disorder continuing education program consist of five (5) courses comprising discrete building blocks: understanding opioid addiction, knowledge of opioid addition treatment, application to practice, and professional readiness - reflective of principles chronicled in Technical Assistance Publication (TAP) Series 21: Addiction Counseling Competencies, emphasizing standards for substance abuse professionals.

TAP 21 has been widely distributed by SAMHSA’s National Clearinghouse for Alcohol and Drug Information (NCADI) and the ATTC Network. It has become a benchmark by which curricula are developed and educational programs and professional standards are measured for the field of substance abuse treatment in the United States. 

Assessing & Addressing Opioid Use Disorder (1.5 CEH)

History & Epidemiology of Opioid Use Disorder (3 CEH)

Comprehensive Assessment of Opioid Use Disorder (3 CEH)

Treatment of Opioid Use Disorder (3 CEH)

Ethical & Legal Standards In Opioid Use Disorder (3 CEH)


  • Understand the history, and epidemiology of opioid-related disorders;

  • Identify general principles of screening, assessment, and diagnosis of opioid-related disorders;

  • Comprehend accepted principles and essential components of treatment, and documentation;

  • Characterize general ethical and legal principles in the treatment of opioid-related disorders;

  • and more.


Registration: FREE          DEADLINE: December 16, 2023

Asynchronous (On Demand/Anytime)


Lakesha Collins - Patterson, APRN

Jacqueline L. Meyers, Ph.D., LPC-S, LAC, NCC

Jacqueline Mims, Ed.D, Ph.D, LPC-S, MAC


Funding for this conference was made possible (in part) by Agreement # 5756 from the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

bottom of page